About Lungpacer
Lungpacer is a company based in Vancouver (Canada) founded in 2009.. Lungpacer has raised $121.38 million across 7 funding rounds from investors including Canadian Institutes of Health Research and Military Health. Lungpacer offers products and services including AeroPace System and AeroNova System. Lungpacer operates in a competitive market with competitors including Belluscura, hemovent, ALung, OneBreath and Securisyn, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lungpacer Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$121.38 M (USD)
in 7 rounds
-
Latest Funding Round
$10 M (USD), Series B
Mar 18, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lungpacer
Lungpacer offers a comprehensive portfolio of products and services, including AeroPace System and AeroNova System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Stimulates diaphragm to aid weaning from mechanical ventilation.
Used for clinical investigations in breathing support technologies.
Unlock access to complete
Unlock access to complete
Funding Insights of Lungpacer
Lungpacer has successfully raised a total of $121.38M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $10.0M
-
First Round
First Round
(13 Mar 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series B - Lungpacer | Valuation |
investors |
|
| Apr, 2022 | Amount | Series B - Lungpacer | Valuation |
investors |
|
| Jan, 2021 | Amount | Grant - Lungpacer | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lungpacer
Lungpacer has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Canadian Institutes of Health Research and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location | |
|
Health research projects in Canada are funded and supported.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lungpacer
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lungpacer
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lungpacer Comparisons
Competitors of Lungpacer
Lungpacer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, hemovent, ALung, OneBreath and Securisyn, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of medical devices for laparoscopic procedures
|
|
| domain | founded_year | HQ Location |
Equipment for extracorporeal life support and CO2 removal is developed.
|
|
| domain | founded_year | HQ Location |
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
|
|
| domain | founded_year | HQ Location |
Portable mechanical ventilators for intensive care patients are developed.
|
|
| domain | founded_year | HQ Location |
Endotracheal tube stabilization systems for ventilated patients are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lungpacer
Frequently Asked Questions about Lungpacer
When was Lungpacer founded?
Lungpacer was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Where is Lungpacer located?
Lungpacer is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Who is the current CEO of Lungpacer?
Doug Evans is the current CEO of Lungpacer.
Is Lungpacer a funded company?
Lungpacer is a funded company, having raised a total of $121.38M across 7 funding rounds to date. The company's 1st funding round was a Grant of $5.36M, raised on Mar 13, 2013.
What does Lungpacer do?
Lungpacer was founded in 2009 in Vancouver, Canada, within the medical device sector focused on respiratory health. A neurostimulation system is provided by the company, utilizing minimally invasive transvascular technology to activate the diaphragm. Electrodes are inserted intravenously to enable rhythmic stimulation, restoring negative pressure ventilation. Pacing therapy is applied to prevent or reverse diaphragm muscle atrophy and sustain endurance. Operations center on this technology for clinical applications.
Who are the top competitors of Lungpacer?
Lungpacer's top competitors include Belluscura, hemovent and ALung.
What products or services does Lungpacer offer?
Lungpacer offers AeroPace System and AeroNova System.
Who are Lungpacer's investors?
Lungpacer has 2 investors. Key investors include Canadian Institutes of Health Research, and Military Health.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.